Hikal
Ticker > Company >

Hikal share price

Hikal Ltd.

NSE: HIKAL BSE: 524735 SECTOR: Pharmaceuticals & Drugs  1.19 L   359   47

259.20
-2.85 (-1.09%)
BSE: 08 Sep 04:01 PM

Price Summary

Today's High

₹ 263.5

Today's Low

₹ 258.85

52 Week High

₹ 464.5

52 Week Low

₹ 245.3

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 3195.96 Cr.

Enterprise Value

₹ 3940.16 Cr.

No. of Shares

12.33 Cr.

P/E

50.73

P/B

2.58

Face Value

₹ 2

Div. Yield

0.54 %

Book Value (TTM)

₹  100.52

CASH

₹ 17.9 Cr.

DEBT

₹ 762.1 Cr.

Promoter Holding

68.85 %

EPS (TTM)

₹  5.11

Sales Growth

-11.79%

ROE

5.99 %

ROCE

7.82%

Profit Growth

-11.31 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year4.21%
3 Year-1.44%
5 Year4.29%

Profit Growth

1 Year30.09%
3 Year-17.69%
5 Year1.17%

ROE%

1 Year7.42%
3 Year6.84%
5 Year10.36%

ROCE %

1 Year9.89%
3 Year8.73%
5 Year11.51%

Debt/Equity

0.6038

Price to Cash Flow

11.4

Interest Cover Ratio

2.6927

CFO/PAT (5 Yr. Avg.)

2.48985784441407

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 68.85 0.00
Mar 2025 68.85 0.00
Dec 2024 68.85 0.00
Sep 2024 68.85 0.00
Jun 2024 68.85 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 33.8793 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.48985784441407.
  • The company has a high promoter holding of 68.85%.

 Limitations

  • The company has shown a poor profit growth of -17.2652107932885% for the Past 3 years.
  • The company has shown a poor revenue growth of -1.44348626262725% for the Past 3 years.
  • Company has a poor ROE of 6.84326666666667% over the past 3 years.
  • The company is trading at a high PE of 50.73.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 406.8 452.9 447.7 552.4 380.4
Total Expenditure 348.7 378.2 375.5 428.9 355.6
Operating Profit 58.1 74.7 72.2 123.5 24.8
Other Income 0.5 0.4 3.6 0.5 1
Interest 19.8 18.8 18.7 17.9 17.1
Depreciation 31.8 31.7 33.2 37.7 39.4
Exceptional Items 0 0 0 0 0
Profit Before Tax 7 24.6 23.9 68.4 -30.7
Tax 1.8 6.5 6.6 18.1 -8
Profit After Tax 5.2 18.1 17.3 50.3 -22.7
Adjusted EPS (Rs) 0.42 1.47 1.4 4.07 -1.84

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 1720.44 1942.72 2023.03 1784.6 1859.8
Total Expenditure 1397.55 1602.16 1765.97 1517.7 1531.3
Operating Profit 322.89 340.57 257.06 266.9 328.5
Other Income 4.98 4.89 5.41 2.5 5
Interest 36.2 31.22 48.1 56.4 75.2
Depreciation 85.25 95.67 109.01 117.6 134.4
Exceptional Items 0 0 0 0 0
Profit Before Tax 206.43 218.57 105.36 95.4 123.9
Tax 73.29 58.06 26.98 25.9 33
Net Profit 133.14 160.51 78.38 68.8 89.5
Adjusted EPS (Rs.) 10.8 13.02 6.36 5.63 7.36

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 24.66 24.66 24.66 24.7 24.7
Total Reserves 908.76 1043.35 1108.83 1162.9 1237.5
Borrowings 262.89 286.68 489.88 422.9 367.2
Other N/C liabilities 116.1 145.22 100.58 220.1 165.9
Current liabilities 703.3 828.13 661.53 932.8 1011.1
Total Liabilities 2015.71 2328.04 2385.48 2763.4 2806.4
Assets
Net Block 712.55 879.46 948.31 1070.6 1364.5
Capital WIP 245.39 285.18 402.08 414.3 121.2
Intangible WIP 8.85 9.6 10.08 0 0
Investments 0.62 0.65 5.31 5.4 9.5
Loans & Advances 117.82 128.77 75.91 129.4 91.2
Other N/C Assets 5.36 1.13 4.78 1 1.8
Current Assets 925.12 1023.25 939.01 1142.7 1218.2
Total Assets 2015.71 2328.04 2385.48 2763.4 2806.4
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 206.43 218.57 105.36 95.4 123.9
Adjustment 126.99 126.27 163.13 174.9 215.1
Changes in Assets & Liabilities -57.9 18.69 75.6 -53.4 -28.8
Tax Paid -46.5 -69.8 -28.8 -30.3 -29.8
Operating Cash Flow 229.02 293.73 315.29 186.6 280.4
Investing Cash Flow -156.2 -284.37 -292.34 -173.7 -136.5
Financing Cash Flow -96.87 -5.56 -7.68 -27 -143.6
Net Cash Flow -24.05 3.8 15.27 -14.1 0.3

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 68.85 68.85 68.85 68.85 68.85
anika trust 0.06 0.06 0.06 0.06 0.06
anish dilip swadi 0.01 0.01 0.01 0.01 0.01
anish trust 0.06 0.06 0.06 0.06 0.06
ashok vishwanath hiremath... 0.08 0.08 0.08 0.08 0.08
bf investment limited 2.65 2.65 2.65 2.65 2.65
jai v hiremath 1.09 1.09 1.09 1.09 1.09
kalyani investment compan... 31.36 31.36 31.36 31.36 31.36
nihal trust 0.06 0.06 0.06 0.06 0.06
pallavi anish swadi 0.31 0.31 0.31 0.31 0.46
pooja hiremath 0.01 0.01 0.01 0.01 0.01
pooja trust 0.06 0.06 0.06 0.06 0.06
rhea trust 0.06 0.06 0.06 0.06 0.06
sameer jai hiremath 0.32 0.32 0.32 0.32 0.32
sameer trust 0.15 0.15 0.15 0.15 0.15
shri badrinath investment... 16.15 16.15 16.15 16.15 16.20
shri rameshwara investmen... 7.96 7.96 7.96 7.96 8.32
sugandha j hiremath 7.84 7.84 7.84 7.84 7.84
sumer trust 0.06 0.06 0.06 0.06 0.06
decent electronics pvt lt... 0.04 0.04 0.04 0.04 -
ekdant investment pvt ltd... 0.32 0.32 0.32 0.32 -
karad engineering consult... 0.05 0.05 0.05 0.05 -
pallavi trust 0.15 0.15 0.15 0.15 -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 31.15 31.15 31.15 31.15 31.15
investor education and pr... - 0.23 0.23 - 0.23
llp 0.13 0.13 0.13 0.15 0.17
tata mutual fund - tata s... 2.68 2.68 2.68 2.68 2.68
theleme india master fund... 1.69 1.69 1.69 1.69 1.45
government pension fund g... 2.71 2.51 1.98 1.65 -
investor education and pr... 0.23 - - 0.23 -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit ICRA
Credit ICRA
Credit ICRA
TYPE AGENCY Link
TYPE AGENCY Link
Research BP Wealth
Research ICICI Securities
Research BP Wealth
Research ICICI Securities Limited

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY22
Concall Q3FY24
Concall Q3FY24
Concall Q2FY23
Concall Q2FY21
Concall Q2FY20
Concall Q1FY25
Concall Q1FY23
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY25
Presentation Q4FY24
Presentation Q4FY22
Presentation Q4FY21
Presentation Q3FY25
Presentation Q3FY24
Presentation Q3FY22
Presentation Q2FY24
Presentation Q2FY22
Presentation Q1FY22
Presentation Q1FY21
Presentation Q1FY20

Company News

Hikal - Quaterly Results 7 Aug, 2:15 PM Hikal - Quaterly Results 7 Aug, 2:15 PM Hikal - Quaterly Results 7 Aug, 2:15 PM Hikal informs about disclosure 16 Jul, 4:59 PM Hikal informs about compliance certificate 7 Jul, 1:41 PM Hikal passes ANVISA’s GMP audit for Jigani unit 17 Jun, 10:30 AM Hikal - Quaterly Results 14 May, 2:22 PM Hikal - Quaterly Results 14 May, 2:22 PM Hikal - Quaterly Results 14 May, 2:22 PM Hikal informs about submission of unaudited financial results 4 Feb, 5:16 PM Hikal - Quaterly Results 4 Feb, 3:08 PM Hikal - Quaterly Results 4 Feb, 3:08 PM Hikal - Quaterly Results 4 Feb, 3:08 PM Hikal informs about disclosure 13 Jan, 4:48 PM HIKAL informs about change in management 26 Dec, 3:55 PM Hikal informs about analyst meet 13 Nov, 3:34 PM Hikal - Quaterly Results 12 Nov, 2:33 PM Hikal - Quaterly Results 12 Nov, 2:33 PM Hikal - Quaterly Results 1 Aug, 2:48 PM Hikal - Quaterly Results 1 Aug, 2:48 PM Hikal - Quaterly Results 1 Aug, 2:48 PM HIKAL informs about disclosure 22 Jul, 2:56 PM Hikal informs about closure of trading window 26 Jun, 2:02 PM Hikal - Quaterly Results 9 May, 3:25 PM Hikal - Quaterly Results 9 May, 3:25 PM Hikal - Quaterly Results 9 May, 3:25 PM Hikal informs about certificate 23 Apr, 3:47 PM Hikal informs about disclosure 23 Feb, 2:33 PM Hikal - Quaterly Results 8 Feb, 8:10 PM Hikal - Quaterly Results 8 Feb, 8:10 PM Hikal informs about disclosure 6 Jan, 12:55 PM HIKAL informs about disclosure 29 Dec, 4:45 PM Hikal - Quaterly Results 2 Nov, 2:57 PM Hikal - Quaterly Results 2 Nov, 2:57 PM Hikal - Quaterly Results 2 Nov, 2:57 PM Hikal informs about press release 31 Aug, 3:32 PM Hikal - Quaterly Results 8 Aug, 3:14 PM Hikal - Quaterly Results 8 Aug, 3:14 PM Hikal - Quaterly Results 8 Aug, 3:14 PM Hikal - Quaterly Results 29 May, 4:11 PM Hikal - Quaterly Results 29 May, 4:11 PM Hikal - Quaterly Results 29 May, 4:11 PM Hikal informs about board meeting 22 May, 4:17 PM Hikal informs about press release 15 May, 11:57 AM USFDA inspects Hikal’s pharmaceutical manufacturing facility at Panoli 15 May, 10:41 AM Hikal informs about press release 2 Feb, 4:24 PM Hikal - Quaterly Results 2 Feb, 3:07 PM Hikal - Quaterly Results 2 Feb, 3:07 PM Hikal - Quaterly Results 2 Feb, 3:07 PM Hikal informs about analyst meet intimation 30 Jan, 4:16 PM

Hikal Stock Price Analysis and Quick Research Report. Is Hikal an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Hikal. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Hikal has a PE ratio of 50.8073196986006 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Hikal has ROA of 2.8532% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Hikal has a Current ratio of 1.2774.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Hikal has a ROE of 5.9895%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Hikal has a Debt to Equity ratio of 0.686 which means that the company has low proportion of debt in its capital.

  • Sales growth: Hikal has reported revenue growth of -11.7858% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Hikal for the current financial year is 17.6631895902785%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Hikal is Rs 1.2 and the yield is 0.5396%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Hikal is Rs 5.1095. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Hikal in Ticker for free. Also, one can get the intrinsic value of Hikal by using Valuation Calculators, which are available with a Finology ONE subscription. 

Hikal FAQs

Q1. What is Hikal share price today?
Ans: The current share price of Hikal is Rs 259.6.

Q2. What is the market capitalisation of Hikal?
Ans: Hikal has a market capitalisation of Rs 3200.88747 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Hikal?
Ans: The PE ratio of Hikal is 50.8073196986006 and the P/B ratio of Hikal is 2.5824858515389, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Hikal share?
Ans: The 52-week high share price of Hikal is Rs 464.75, and the 52-week low share price of Hikal is Rs 245.

Q5. Does Hikal pay dividends?
Ans: Currently, Hikal pays dividends. Dividend yield of Hikal is around 0.5396%.

Q6. What are the face value and book value of Hikal shares?
Ans: The face value of Hikal shares is Rs 2, while the book value per share of Hikal is around Rs 100.5233. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Hikal?
Ans: Hikal has a total debt of Rs 762.1 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Hikal?
Ans: The ROE of Hikal is 5.9895% and ROCE of Hikal is 7.8162%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Hikal a good buy for the long term?
Ans: The Hikal long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Hikal undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Hikal appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Hikal’s financials?
Ans: You can review Hikal’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Hikal

Hikal Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Hikal Ltd. is a leading Indian chemical manufacturer with a global footprint. The company was established in 1988 and is headquartered in Bangalore, India. Hikal has a strong presence in the pharmaceutical, crop protection, and specialty chemicals markets and has numerous manufacturing facilities across India, Europe, and the USA. The company is committed to sustainable growth and innovation while maintaining a high level of social and environmental responsibility.

Hikal Ltd. Share Price

Hikal Ltd. is a publicly traded company on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) in India. The share price of Hikal can be tracked on our website's stock analysis page. Our pre-built screening tools provide a real-time view of the company's share price movement and allow investors to track the stock's performance over time.

Hikal Ltd. Balance Sheet

A company's balance sheet is a snapshot of a company's financial position at a given point in time. Hikal Ltd.'s balance sheet can be found on our website, alongside our premium feature tools used for fair value calculation, including DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. Our premium tools allow investors to do a deep dive and better understand Hikal's financial position.

Hikal Ltd. Annual Report

The annual report is an important document that provides insights into a company's performance over the year. Hikal's annual reports are available for download on our website's stock analysis page. The reports include information on the company's revenue, earnings, and overall performance, providing investors with a comprehensive understanding of Hikal's operations.

Hikal Ltd. Dividend

Hikal Ltd.'s dividend history can be found on our website's stock analysis page. Tracking a company's dividend history is important for investors who seek long-term investments as dividends are an important source of income. Our pre-built screening tools provide relevant metrics on dividend yield, payout history, and dividend growth, allowing investors to make informed decisions on Hikal Ltd.

Hikal Ltd. Quarterly Result

The quarterly results of Hikal Ltd. are available for download on our website. The reports include information on the company's revenue, earnings, and overall performance for a particular quarter. Our premium feature tools, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, allow investors to delve deeper into Hikal's quarterly results and make more informed decisions.

Hikal Ltd. Stock Price

Tracking the stock price of a company is important for investors who seek long-term investments. Our pre-built screening tools on the Hikal Ltd. stock analysis page provide real-time updates on the company's stock price movement, high and low trading volumes, and relative strength indicators.

Hikal Ltd. Price Chart

Our website's stock analysis page features the price charts of Hikal Ltd. The price charts track the company's price trend over the years, allowing investors to identify long-term price trends and patterns. It is important for investors to understand price movements before making investment decisions.

Hikal Ltd. News

Our website's stock analysis page offers up-to-date news articles related to Hikal Ltd. News articles include company announcements, industry news, and market updates that may impact Hikal Ltd's share price. Investors can stay informed on the latest news related to Hikal Ltd. and make informed investment decisions.

Hikal Ltd. Concall Transcripts

Hikal Ltd.'s concall transcripts provide investors with detailed information on the company's earnings and performance. Our website provides downloadable concall transcripts for Hikal Ltd. that allow investors to read through a transcript of the analyst call. The transcripts are helpful for investors who want to understand the analyst's queries related to the company's earnings and operations.

Hikal Ltd. Investor Presentations

Hikal Ltd.'s investor presentations are available for download on our website's stock analysis page. Investor presentations provide valuable insights into a company's operations, growth plans, and financial performance. Our website offers a complete set of investor presentations, which are essential for investors seeking a comprehensive understanding of Hikal's business.

Hikal Ltd. Promoters

Hikal Ltd.'s promoters are the individuals or entities that are responsible for the overall management and strategic vision of the company. Our website's stock analysis page provides information related to Hikal Ltd.'s shareholders, ownership structure, and promoter holdings.

Hikal Ltd. Shareholders

Shareholders are important stakeholders in a company, and their investment decisions can impact the company's operations. Our website's stock analysis page provides information on Hikal Ltd.'s shareholders, including institutional and retail investors. Understanding shareholder patterns and trends can help investors make informed investment decisions.

Overall, our website's stock analysis page provides investors with a comprehensive set of tools to analyze Hikal Ltd. and make informed investment decisions. Our pre-built screening tools provide real-time updates on the company's stock price, dividend history, and other relevant metrics, while our premium features allow investors to perform a deep dive analysis of Hikal Ltd's financial position. 

Hikal's Growing Reserves Reflect Financial Fortitude

Over the span of five years, Hikal's total reserves have seen a steady climb from Rs 791.86 Cr in March 2020 to Rs 1,162.93 Cr by March 2024. This continuous growth hints at robust internal resource generation and an encouraging reserve buffer.

Stability in Hikal's Share Capital

The consistency in Hikal's share capital at Rs 24.66 Cr from March 2020 to March 2024 suggests a stable equity structure, without any additional equity dilution over the years.

Trend of Hikal's Borrowings and Debt Management

Hikal's borrowings show a dynamic pattern, with a drop to Rs 262.89 Cr in March 2021, followed by an increase to Rs 489.88 Cr in March 2023, and a subsequent reduction to Rs 422.85 Cr by March 2024. This indicates a responsive debt management strategy over the years.

Hikal's Asset Base Expansion

Net Block assets have registered growth from Rs 735.22 Cr to Rs 1,070.63 Cr by March 2024, suggesting investment in growth and infrastructure. Meanwhile, a flourishing Capital WIP from Rs 152.10 Cr in March 2020 to Rs 414.34 Cr in March 2024 indicates ongoing development projects.

Consistency in Hikal's Current Assets

Hikal maintained a strong position in current assets with an increase from Rs 831.22 Cr in March 2020 to Rs 966.53 Cr by March 2024, reflecting solid liquidity and operational efficiency.

This data is an analysis for the Standalone Balance sheet of the company. While focusing on company profiles, investors may also consider broader indices such as NSE or BSE and their alignments with sectors like pharmaceuticals, where Hikal is making its mark.

Read More
X